Clinical trial investigates new oral treatment for COVID-19

An exploratory clinical trial (SIGMA4COVID) through a collaboration between Catalonia and Galicia, the results of which are published in the Journal of Infection, suggests the usefulness of a drug, E-52862, for the treatment of patients with mild COVID-19 symptoms. If these findings are confirmed, it will be one of the few useful treatments in these cases, with the addition that it could be administered on an outpatient basis through primary care centers.